Skip to main content

BRIEF-Akers Biosciences Q2 loss before income tax $1 million

* Revenue for three months ended June 30, 2016 totaled $956,486, a 1% decrease from three months ended june 30, 2015. Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.